Spectral AIMDAI -0.58%6 EBITDA Margin % is -70.36% as of Mar. 2026. GuruFocus rates MDAI with a GF Score™ of 6/100 and a GF Value™ of $0.91 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 813 Medical Devices & Instruments companies, Spectral AI ranks worse than 74.54% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Spectral AI's EBITDA for the
three
months ended in Mar. 2026 was $-2.81 Mil. Spectral AI's Revenue for the
three
months ended in Mar. 2026 was $3.99 Mil. Therefore, Spectral AI's EBITDA margin for the quarter that ended in Mar. 2026 was -70.36%.
Spectral AI (NAS:MDAI) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Spectral AI EBITDA Margin % Related Terms
Spectral AI EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Spectral AI's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MDAI vs LUNG, QTI, COCH: EBITDA Margin % Comparison
For the Medical Devices subindustry, Spectral AI's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Spectral AI EBITDA Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Spectral AI's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Spectral AI's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Spectral AI (MDAI) has a EBITDA Margin % of -70.36% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Spectral AI and its competitors. According to the industry distribution chart, Spectral AI ranks #606 out of 813 companies in the Medical Devices & Instruments industry, placing it in the top 74.5%.
Is Spectral AI's EBITDA Margin % too high?
Spectral AI's current EBITDA Margin % is -70.36%. Based on the distribution chart, Spectral AI ranks #606 out of 813 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Spectral AI has a GF Score™ of 6/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Spectral AI's EBITDA Margin % compare to LUNG and QTI?
According to the Medical Devices & Instruments industry distribution chart, Spectral AI ranks #606 out of 813 companies for EBITDA Margin %. This places Spectral AI in the lower half of its industry. The industry median EBITDA Margin % is 7.47. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 7.47, based on 813 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Spectral AI and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Spectral AI's current EBITDA Margin % is -70.36%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Spectral AI stock overvalued right now?
Based on GuruFocus' analysis, Spectral AI (MDAI) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.91, compared to a current price of $1.72 — trading 89% above its estimated fair value. The current EBITDA Margin % is -70.36%. Spectral AI's overall GF Score™ is 6/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Spectral AI (MDAI), the current EBITDA Margin % is -70.36% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Spectral AI (MDAI) Overvalued in 2026?
Based on GuruFocus' analysis, Spectral AI stock appears to be overvalued.
The current stock price of $1.72 is trading 89% above its estimated GF Value™ of $0.91.
GuruFocus considers Spectral AI to be Significantly Overvalued.
Key valuation signals for MDAI:
EBITDA Margin %: -70.36%
GF Value™: $0.91 vs. price of $1.72 (89% above fair value)
No single metric tells the full story. See the MDAI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Spectral AI Inc is an AI company focused on predictive medical diagnostics. Its DeepView System uses proprietary AI algorithms to distinguish between fully damaged, partially damaged and healthy human tissue characters invisible to the naked eye, at the initial time point of wound presentation. The DeepView System delivers a binary prediction on the wound's capacity to heal or not-heal by a specified time point in the future. The company focuses on the burn indication which is supported by the BARDA PBS contract.
6GF Score
Get the complete analysis for MDAI
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MDAI has been successfully added to your 
